Editor's Picks

Event: CMTs “Virtual Medical-Business Breakfast” with Jo Bhakdi, the founder and CEO of Quantgene

Click here to attend (FREE) and register for CMTs “Virtual Medical-Business Breakfast”

By Michael Tetreault, Editor-in-Chief, Concierge Medicine Today

We are excited to bring you our next digital “CMT For Doctors Business Breakfast” with Jo Bhakdi, the founder and CEO of Quantgene. His work in cancer detection, machine learning, sequencing technology, and DNA extraction procedures defines the cutting edge of genomic diagnostics, early disease detection, and precision medicine. Beyond his focus on technology and the future of medicine, Bhakdi is dedicated to bringing together the best and brightest and transforming them into pioneers, pushing the boundaries of health, life, and innovation for all.

Jo will join Concierge Medicine Today (CMT) Editor-in-Chief, Michael Tetreault for a conversation about several things Doctors can do to remain up-to-date on early detection and cancer screening technology.

  • WHEN: Thursday, July 23 at 7:30 a.m. EST
  • WHO: Jo Bhakdi, the founder and CEO of Quantgene



Learn More, Visit: https://www.quantgene.com/

Serenity provides deeper genetic insights to keep you safer from chronic diseases, drug interactions and lifestyle risks. ‍

Prior to Quantgene, Jo founded i2X, an investment framework that composes low-risk Venture Capital portfolios across large numbers of technology startups. The i2X platform laid important foundations for advanced analytics in both financial and biotechnology applications, such as the Quantgene machine learning platform. ‍

Bhakdi holds a Masters in Economics and Psychology from Tubingen University, one of Germany’s leading academic institutions, with a focus on financial theory and statistics. He kicked off his career at WPP and Omnicom, where he held Strategy and Executive Director positions.

Learn More, Visit: https://www.quantgene.com/